Respiratory Syncytial Virus (RSV) remains a significant health concern, particularly for older adults and those with underlying risk factors. Currentrecommendations advise RSV vaccination for all individuals aged 75 and older, aswell as adults aged 50 to 74 who are at increased risk of severe illness. Notably,residing in a nursing home is considered a key risk factor.

As healthcare providers and caregivers evaluate vaccination options, it’simportant to consider solutions that support efficiency, safety, and patientcomfort. Here’s why Abrysvo is a strong choice across the board:

1. A Smart Choice for Administrators

Abrysvo offers a cost advantage, coming in at approximately $50 per dose lessthan other RSV vaccines. This makes it a budget-friendly option withoutcompromising quality of care.

2. Simplified Administration for Nursing Staff

Designed with ease of use in mind, Abrysvo utilizes Act-o-Vial technology tostreamline preparation and administration. With a simple press, the diluent isreleased into the powder chamber—eliminating the need for measuring ortransferring. This not only saves time but also helps reduce the risk of medicationerrors.

3. A Comfortable Experience for Patients

While RSV vaccines generally share similar safety profiles, Abrysvo is associated with slightly fewer side effects, such as headaches, muscle aches, and fatigue—helping improve the overall patient experience.

Unlike vaccines that require annual doses, Abrysvo is administered as a single,one-time shot. This simplifies care planning and improves adherence—making it an easy win for both patients and providers.

If you have questions about RSV vaccination or would like more information about Abrysvo, the team at SpecialtyRx is here to help. Reach out anytime tospeak with a pharmacist and ensure you’re making the best choice for yourpatients.

‍